000 01697 a2200421 4500
005 20250514053734.0
264 0 _c20030205
008 200302s 0 0 eng d
022 _a0007-1048
024 7 _a10.1046/j.1365-2141.2003.03930.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aStritzke, Jan
245 0 0 _aTherapeutic effects of idiotype vaccination can be enhanced by the combination of granulocyte-macrophage colony-stimulating factor and interleukin 2 in a myeloma model.
_h[electronic resource]
260 _bBritish journal of haematology
_cJan 2003
300 _a27-35 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAdjuvants, Immunologic
_xtherapeutic use
650 0 4 _aAnimals
650 0 4 _aAntigens, Tumor-Associated, Carbohydrate
_xadministration & dosage
650 0 4 _aCancer Vaccines
_xadministration & dosage
650 0 4 _aGranulocyte-Macrophage Colony-Stimulating Factor
_xtherapeutic use
650 0 4 _aImmunoglobulin Idiotypes
_xadministration & dosage
650 0 4 _aInterleukin-2
_xtherapeutic use
650 0 4 _aMice
650 0 4 _aMice, Inbred BALB C
650 0 4 _aMultiple Myeloma
_ximmunology
650 0 4 _aNeoplasms, Experimental
650 0 4 _aSurvival Rate
650 0 4 _aT-Lymphocytes, Cytotoxic
_ximmunology
650 0 4 _aTumor Cells, Cultured
700 1 _aZunkel, Tim
700 1 _aSteinmann, Jörg
700 1 _aSchmitz, Norbert
700 1 _aUharek, Lutz
700 1 _aZeis, Matthias
773 0 _tBritish journal of haematology
_gvol. 120
_gno. 1
_gp. 27-35
856 4 0 _uhttps://doi.org/10.1046/j.1365-2141.2003.03930.x
_zAvailable from publisher's website
999 _c12296656
_d12296656